Extremely high levels of prolactin such as those you have described are generally an indication of a pituitary tumour or other physiological disruption.
The level of prolactin reached before symptoms would be seen is hard to say, as different people respond so vastly different to hormones. I for example was slightly lactating with a prolactin level of 22.0 ng/ml (range: 0-20.0 ng/ml). It had been higher before when I was on lexapro (I believe about 30 ng/ml) and I was still able to function sexually, however reaching climax was more difficult and sex less pleasurable overall.
Even after I was off of all SSRI's, my prolactin remained elevated for months until I started Mirapex, and even then it wasn't overnight.
Okay, so I went in yesterday for my blood work, and I should have results within 1 week. I had the following tests done:
ACTH
DHEA
DHT
Estradiol
FSH
LH
Pregnenolone
Prolactin
SHBG
Testosterone Free and Total
**I have the option of adding additional tests and panels on Monday (it's Friday, today). If you look at this hormonal-biosynthesis pathway, you'll see how testosterone, DHT, and everything else is created:
Case in point, I want to test everything in the pathway leading to testosterone, DHT, and estradiol. That would mean adding the following tests:
17a-hydroxyprogesterone
17a-hydroxypregnenolone
Progesterone
Androstenedione
Further, they offer a 5-alpha reductase profile, and I want to get that, too.
Also, I've been looking into other therapies for erectile dysfunction that aren't based on PDE5 inhibitors. Specifically, gene and stem cell therapy. There is a doctor here in LA that performs stem cell therapy for erectile dysfunction. I have an appointment with him on Tuesday of next week.
Here is my current research on the non-PDE5 treatments for ED that I've found:
IGF-1 Treatment
Insulin-like growth factor-1 restores erectile fun... [J Sex Med. 2008] - PubMed - NCBI
"Insulin-like growth factor-1 restores erectile function in aged rats: modulation the integrity of smooth muscle and nitric oxide-cyclic guanosine monophosphate signaling activity.
Pu XY, Wang XH, Gao WC, Yang ZH, Li SL, Wang HP, Wu YL.
INTRODUCTION:
Insulin-like growth factor-1 (IGF-1) is one of the growth factors that have a wide range of biologic effects. We have confirmed that gene transfer of IGF-1 to the penis could improve erectile capacity. However, there are some limitations in gene therapies, such as toxicity or a risk of insertional mutagenesis. Protein treatment may be another choice for decreasing these risks.
AIM:
To investigate whether intracavernosal injection of IGF-1 protein can restore erectile function in the aging rat.
MAIN OUTCOME MEASURES:
Erectile responses, morphological changes, and nitric oxide-cyclic guanosine monophosphate (NO-cGMP) signaling pathways-related marker were determined.
METHODS:
Ten young (4 months) and 30 old (24 months) Sprague-Dawley male rats were enrolled in this study. The old rats were divided into three groups: vehicle-only (N = 10), IGF-1 1 microg/kg (N = 10) and IGF-1 10 microg/kg treatment group (N = 10). After 4 and 8 weeks of single IGF-1 injection treatment, intracavernous pressure (ICP) responses with electrical stimulation to the cavernous nerve were evaluated. The percent of smooth muscle in corpus cavernosum tissue, the expression of mRNA and protein of endothelial nitric oxide synthase (eNOS) were also evaluated. The activity of nitric oxide synthase (NOS) and concentration of guanosine 3',5'-cyclic-monophosphate (cGMP) that act upon the major NO-cGMP signaling pathways in penile tissue were also analyzed.
RESULTS:
After IGF-1 treatment, the ICP responses was significantly increased as the young control group in both the IGF-1 1 microg/kg and the IGF-1 10 microg/kg group compared with the vehicle-only group at 4 and 8 weeks (P < 0.05). Masson's trichrom staining showed the percentage of cavernosal smooth muscle was increased in IGF-1 treatment group. IGF-1 increased e-NOS expression. NOS activities and cGMP concentrations were also significantly increased in IGF-1 treatment rats.
CONCLUSIONS:
IGF-1 improved erectile function in aged rats via restoration the integrity of smooth muscle of corpus cavernosum and modulation of NO-cGMP pathways."
Adipose Derived Stem Cells for Treatment of Erectile Dysfunction
Potential of adipose-derived stem cells for treatm... [J Sex Med. 2009] - PubMed - NCBI
"J Sex Med. 2009 Mar;6 Suppl 3:320-7.
Potential of adipose-derived stem cells for treatment of erectile dysfunction.
Lin G, Banie L, Ning H, Bella AJ, Lin CS, Lue TF.
INTRODUCTION:
Adipose-derived stem cells (ADSCs) are a somatic stem cell population contained in fat tissue that possess the ability for self-renewal, differentiation into one or more phenotypes, and functional regeneration of damaged tissue, which may benefit the recovery of erectile function by using a stem cell-based therapy.
AIM:
To review available evidence concerning ADSCs availability, differentiation into functional cells, and the potential of these cells for the treatment of erectile dysfunction (ED).
METHODS:
We examined the current data (from 1964 to 2008) associated with the definition, characterization, differentiation, and application of ADSCs, as well as other kinds of stem cells for the cell-based therapies of ED.
MAIN OUTCOME MEASURES:
There is strong evidence supporting the concept that ADSCs may be a potential stem cell therapy source in treating ED.
RESULTS:
The ADSCs are paravascularly localized in the adipose tissue. Under specific induction medium conditions, these cells differentiated into neuron-like cells, smooth muscle cells, and endothelium in vitro. The insulin-like growth factor/insulin-like growth factor receptor (IGF/IGFR) pathway participates in neuronal differentiation while the fibroblast growth factor 2 (FGF2) pathway is involved in endothelium differentiation. In a preliminary in vivo experiment, the ADSCs functionally recovered the damaged erectile function. However, the underlying mechanism needs to be further examined.
CONCLUSION:
The ADSCs are a potential source for stem cell-based therapies, which imply the possibility of an effective clinical therapy for ED in the near future."
Muscle Derived Stem Cells for Treatment of Erectile Dysfunction
Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat - Nolazco - 2008 - BJU International - Wiley Online Library
"Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat
DOI: 10.1111/j.1464-410X.2008.07507.x
OBJECTIVE
To determine whether skeletal muscle-derived stem cells (MDSCs) convert into smooth muscle cells (SMCs) both in vitro and in vivo, and in so doing ameliorate the erectile dysfunction (ED) of aged rats, and whether endogenous stem cells are present in the rat corpora cavernosa.
MATERIALS AND METHODS
MDSCs were obtained from mouse muscle, and shown by immunocytochemistry for ?-smooth muscle actin (?SMA) to originate in vitro in myofibroblasts and SMCs, discriminating SMCs by calponin 1 expression. In vivo these MDSCs, labelled with 4?,6-diamidino-2-phenylindole, were implanted into the corpora cavernosa of young adult (5-month old) and aged (20-month old) rats for 2 and 4 weeks. Histological changes were assessed by immunohistochemistry and quantitative Western blot. Functional changes were determined by electrical field stimulation (EFS) of the cavernosal nerve.
RESULTS
The exogenous cells replicated and converted into SMCs, as shown in corporal tissue sections by confocal immunofluorescence microscopy for proliferating cell nuclear antigen (PCNA), ?SMA, and smoothelin, and also by Western blot for ?SMA and PCNA. MDSC differentiation was confirmed by the activation of the ?SMA promoter-linked ?-galactosidase in transfected cells, both in vitro and after implantation in the corpora. Putative endogenous stem cells were shown in corporal tissue sections and Western blots by detecting CD34 and a possible Sca1 variant. EFS showed that implanted MDSCs raised in aged rats the maximal intracavernosal pressure/mean arterial pressure levels above (2 weeks) or up to (4 weeks) those of young adult rats.
CONCLUSIONS
MDSCs implanted into the corpora cavernosa of aged rats converted into SMCs and corrected ED, and endogenous cells expressing stem cell markers were also found in untreated tissue. This suggests that exogenous stem cell implantation and/or endogenous stem cell modulation might be viable therapeutic approaches for ageing-related ED."
_______________________________________________________________________
Response to 4-Chloro:
All of your information is extremely helpful. Unfortunately, I believe the test results that I gave first, taken on August 1st (it's now September 9th), are not reflective of my current hormonal state. Therefore, replying in an itemized way to each of your comments will be futile, at best.
All the same, I have been trying to help myself with my ED by getting off of cialis, which I had been taking near-daily for a few weeks, and every three days or so for the last 2 years. I need a break from this medication, to help bring my tolerance to it down, and to give my body a break. I've since been using viagra once daily at 50-75 mg.
Today, and yesterday, I have not had morning erections for the first time in several weeks. I'm not sure if this is due to my estrogen/testosterone ratio, or not, but hopefully, the blood taken yesterday will show some sign of what's going on in this regard.
On a positive note, I had an unassisted, successful erection, yesterday evening. Unfortunately, a reattempt today to have a successful erection failed. I have been off of Cialis for ~4-5 days, now.
I haven't taken any anti-estrogen medications, and have weened down to 150 mg of Wellbutrin per day, and plan on discontinuing it completely in 2 days.
Pending the results of my bloodwork, the appointment I have with the stem cell doctor, and my erectile capacity, we should know more.
What I believe to be the case, at this point, is that the smooth muscle in my penis is atrophied, and that the corpus cavernosum more than likely has fibrosis, all of this due to estradiol's effects on the tissue, as well as my low levels of testosterone.
My options at this point:
get stem cell therapy
inject IGF-1 into my penis
get onto TRT/HRT if required
Here is the stem cell doctor's website:
MetroMD | HGH Human Growth Hormone | Stem Cell Therapy | Regenerative Medicine | Hollywood | Beverly Hills | Los Angeles
I need to be vigilant with this, and not fall behind. The nature of the body is to atrophy what is disused, and the penis is no exception.